| 74.13 |  +0.23 / +0.31% |
Data as of 4:00pm ET | Day’s Change |
| 74.14 | +0.0148 / +0.02% |
Volume: 8.4K |
| 4 M&A Deal Stocks to Watch in June May 31 / TheStreet.com | Biotech: it's back May 27 / FT.com |
| Life Stock Hits New 52-Week High (LIFE) May 30 / TheStreet.com |
| Previous close | 73.90 |
| Today’s open | 73.95 |
| Day’s range | 73.90 - 74.13 |
| Volume | 3,614,233 |
| Average volume (3 months) | 3,817,139 |
| Market cap | $12.7B |
| Dividend yield | -- |
| Earnings growth (last year) | +17.65% |
| Earnings growth (this year) | +5.70% |
| Earnings growth (next 5 years) | +7.45% |
| Revenue growth (last year) | -1.08% |
| P/E ratio | 31.5 |
| Price/Sales | 2.27 |
| Price/Book | 2.72 |
| Today’s change | Today’s % change | |
|---|---|---|
| GRFSGrifols SA | +0.14 | +0.54% |
| AEGRAegerion Pharmaceuti... | +0.08 | +0.11% |
| IMGNImmunogen Inc | +0.34 | +2.07% |
| GEVASynageva Biopharma C... | +0.69 | +1.74% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $0.97 |
| Annual revenue (last year) | $3.8B |
| Annual profit (last year) | $430.9M |
| Net profit margin | 11.34% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Gregory T. Lucier, MBA |
President & Chief Operating Officer Mark P. Stevenson, MBA |
Corporate headquarters Carlsbad, California |
.
